10th Biennial Helene Harris Memorial Trust Meeting

Frances R. Balkwill, Alan Ashworth, Robert C. Bast, Jonathon S. Berek, Jeff Boyd, Mary L. Disis, Hani Gabra, Martin E. Gore, Thomas C. Hamilton, Ian J. Jacobs, Stan B. Kaye, Elise C. Kohn, Gordon Mills, Nicole D. Urban

Research output: Contribution to journalArticle

Abstract

Improving the prognosis of ovarian cancer patients is a major challenge to scientists and clinicians. At a recent multidisciplinary meeting in Washington DC, advances in identification of precursor lesions, progress in disease biomarkers and animal models, the promise of nanotechnology, and strategies for manipulation of the innate and adaptive immune response offered prospects for real progress in this difficult-to-treat disease.

Original languageEnglish (US)
Pages (from-to)2904-2906
Number of pages3
JournalCancer Research
Volume66
Issue number6
DOIs
StatePublished - Mar 15 2006
Externally publishedYes

Fingerprint

Animal Disease Models
Nanotechnology
Adaptive Immunity
Innate Immunity
Ovarian Neoplasms
Biomarkers

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Balkwill, F. R., Ashworth, A., Bast, R. C., Berek, J. S., Boyd, J., Disis, M. L., ... Urban, N. D. (2006). 10th Biennial Helene Harris Memorial Trust Meeting. Cancer Research, 66(6), 2904-2906. https://doi.org/10.1158/0008-5472.CAN-05-2093

10th Biennial Helene Harris Memorial Trust Meeting. / Balkwill, Frances R.; Ashworth, Alan; Bast, Robert C.; Berek, Jonathon S.; Boyd, Jeff; Disis, Mary L.; Gabra, Hani; Gore, Martin E.; Hamilton, Thomas C.; Jacobs, Ian J.; Kaye, Stan B.; Kohn, Elise C.; Mills, Gordon; Urban, Nicole D.

In: Cancer Research, Vol. 66, No. 6, 15.03.2006, p. 2904-2906.

Research output: Contribution to journalArticle

Balkwill, FR, Ashworth, A, Bast, RC, Berek, JS, Boyd, J, Disis, ML, Gabra, H, Gore, ME, Hamilton, TC, Jacobs, IJ, Kaye, SB, Kohn, EC, Mills, G & Urban, ND 2006, '10th Biennial Helene Harris Memorial Trust Meeting', Cancer Research, vol. 66, no. 6, pp. 2904-2906. https://doi.org/10.1158/0008-5472.CAN-05-2093
Balkwill FR, Ashworth A, Bast RC, Berek JS, Boyd J, Disis ML et al. 10th Biennial Helene Harris Memorial Trust Meeting. Cancer Research. 2006 Mar 15;66(6):2904-2906. https://doi.org/10.1158/0008-5472.CAN-05-2093
Balkwill, Frances R. ; Ashworth, Alan ; Bast, Robert C. ; Berek, Jonathon S. ; Boyd, Jeff ; Disis, Mary L. ; Gabra, Hani ; Gore, Martin E. ; Hamilton, Thomas C. ; Jacobs, Ian J. ; Kaye, Stan B. ; Kohn, Elise C. ; Mills, Gordon ; Urban, Nicole D. / 10th Biennial Helene Harris Memorial Trust Meeting. In: Cancer Research. 2006 ; Vol. 66, No. 6. pp. 2904-2906.
@article{1678d515dd3343ee8102abe503ea2105,
title = "10th Biennial Helene Harris Memorial Trust Meeting",
abstract = "Improving the prognosis of ovarian cancer patients is a major challenge to scientists and clinicians. At a recent multidisciplinary meeting in Washington DC, advances in identification of precursor lesions, progress in disease biomarkers and animal models, the promise of nanotechnology, and strategies for manipulation of the innate and adaptive immune response offered prospects for real progress in this difficult-to-treat disease.",
author = "Balkwill, {Frances R.} and Alan Ashworth and Bast, {Robert C.} and Berek, {Jonathon S.} and Jeff Boyd and Disis, {Mary L.} and Hani Gabra and Gore, {Martin E.} and Hamilton, {Thomas C.} and Jacobs, {Ian J.} and Kaye, {Stan B.} and Kohn, {Elise C.} and Gordon Mills and Urban, {Nicole D.}",
year = "2006",
month = "3",
day = "15",
doi = "10.1158/0008-5472.CAN-05-2093",
language = "English (US)",
volume = "66",
pages = "2904--2906",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "6",

}

TY - JOUR

T1 - 10th Biennial Helene Harris Memorial Trust Meeting

AU - Balkwill, Frances R.

AU - Ashworth, Alan

AU - Bast, Robert C.

AU - Berek, Jonathon S.

AU - Boyd, Jeff

AU - Disis, Mary L.

AU - Gabra, Hani

AU - Gore, Martin E.

AU - Hamilton, Thomas C.

AU - Jacobs, Ian J.

AU - Kaye, Stan B.

AU - Kohn, Elise C.

AU - Mills, Gordon

AU - Urban, Nicole D.

PY - 2006/3/15

Y1 - 2006/3/15

N2 - Improving the prognosis of ovarian cancer patients is a major challenge to scientists and clinicians. At a recent multidisciplinary meeting in Washington DC, advances in identification of precursor lesions, progress in disease biomarkers and animal models, the promise of nanotechnology, and strategies for manipulation of the innate and adaptive immune response offered prospects for real progress in this difficult-to-treat disease.

AB - Improving the prognosis of ovarian cancer patients is a major challenge to scientists and clinicians. At a recent multidisciplinary meeting in Washington DC, advances in identification of precursor lesions, progress in disease biomarkers and animal models, the promise of nanotechnology, and strategies for manipulation of the innate and adaptive immune response offered prospects for real progress in this difficult-to-treat disease.

UR - http://www.scopus.com/inward/record.url?scp=33645521203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645521203&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-05-2093

DO - 10.1158/0008-5472.CAN-05-2093

M3 - Article

VL - 66

SP - 2904

EP - 2906

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 6

ER -